First Affiliated Hospital Researcher Yields New Findings on Antineoplastics (Adverse Event Profiles of the Third-Generation Aromatase Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS).

MLA

“First Affiliated Hospital Researcher Yields New Findings on Antineoplastics (Adverse Event Profiles of the Third-Generation Aromatase Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS).” Drug Week, Aug. 2024, p. 968. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=179024910&authtype=sso&custid=ns315887.

APA

First Affiliated Hospital Researcher Yields New Findings on Antineoplastics (Adverse Event Profiles of the Third-Generation Aromatase Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS). (2024). Drug Week, 968.

Chicago

“First Affiliated Hospital Researcher Yields New Findings on Antineoplastics (Adverse Event Profiles of the Third-Generation Aromatase Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS).” 2024. Drug Week, August, 968. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=179024910&authtype=sso&custid=ns315887.